Drug Profile
Research programme: West Nile virus monoclonal antibodies - Crucell
Alternative Names: WNV monoclonal antibodiesLatest Information Update: 20 Jun 2011
Price :
$50
*
At a glance
- Originator Crucell
- Class Monoclonal antibodies
- Mechanism of Action Virus attachment inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued West Nile virus infections
Most Recent Events
- 14 Aug 2007 Commercial options are being explored for this programme